Avricore Health Inc. Expands HealthTab™ Platform in North Central London

In a significant move to enhance healthcare accessibility, Avricore Health Inc., a pharmaceutical company specializing in the marketing and distribution of generic and over-the-counter pharmaceuticals, has announced the expansion of its innovative HealthTab™ platform into North Central London. This expansion marks a pivotal step in the company’s ongoing efforts to address health inequalities through proactive cardiovascular health management.

The HealthTab™ platform, now deployed in thirteen pharmacies across the UK, is part of a groundbreaking initiative led by the NHS to integrate pharmacy services into the broader healthcare system. This initiative, which began with North East London, now includes North Central London as the second NHS Integrated Care Board (ICB) to adopt the program. The recent expansion involved the deployment of six new HealthTab™ systems, significantly increasing the reach of this initiative.

The primary goal of the HealthTab™ platform is to provide accessible cholesterol screening services, particularly targeting underserved populations. By bringing these services directly to community pharmacies, Avricore Health is not only making preventative testing more accessible but also empowering pharmacists to play a crucial role in chronic disease prevention and patient care. This approach aligns with the UK’s vision of creating a more agile and responsive healthcare system.

Rodger Seccombe, CEO of Avricore Health, emphasized the transformative potential of this initiative. “This initiative is fundamentally changing how healthcare is delivered,” he stated. “By empowering pharmacists to take a leading role in chronic disease prevention and patient care, we’re making healthcare more effective, more accessible, and more responsive to the needs of both patients and providers.”

The expansion into North Central London is expected to bring the HealthTab™ platform to even more patients, further supporting the UK’s efforts to transform community pharmacies into accessible hubs for chronic disease management. This move not only highlights Avricore Health’s commitment to improving public health outcomes but also underscores the company’s strategic focus on leveraging technology to enhance healthcare delivery.

As Avricore Health continues to expand its HealthTab™ platform, the company remains dedicated to reducing health disparities and improving access to essential healthcare services. This initiative represents a significant step forward in the ongoing transformation of the UK’s healthcare landscape, with Avricore Health at the forefront of this innovative journey.